İdiyopatik Fotodermatozlar ve D Vitamini
Özet
Fotodermatozlar, ultraviyole radyasyona veya görünür ışığa karşı ciltte anormal reaksiyonlarla karakterize hastalıklardır ve immünolojik mekanizmalarla gelişen idiyopatik fotodermatozlar (PLE, aktinik prurigo vb.) bu grupta yer alır. En sık görülen tür olan polimorfik ışık erüpsiyonu (PLE) patogenezinde, UV ile indüklenen neoantijenlere karşı gelişen bozulmuş immün yanıt ve T hücre aktivasyonu rol oynamaktadır. Son araştırmalar, D vitamininin immünmodülasyon ve immünsüpresyon üzerindeki kritik rolünü ön plana çıkarmaktadır; nitekim 1,25-(OH)2 D3 vitamini proinflamatuar sitokinleri azaltırken anti-inflamatuar sitokin üretimi ile Treg hücrelerini stimüle eder. Fotodermatoz hastalarında, güneşten kaçınma davranışları ve koruyucu kıyafet/güneş kremi kullanımı nedeniyle kutanöz sentez engellenmekte ve bu durum ciddi D vitamini eksikliği riskine yol açmaktadır. Yapılan çalışmalarda, PLE hastalarında serum D vitamini düzeyleri sağlıklı bireylere kıyasla anlamlı derecede düşük saptanmıştır. Fototerapi uygulamaları ciltte D vitamini üretimini artırıp semptomları hafifletse de, aynı zamanda DNA hasarını da indüklediği için oral takviyeler daha güvenli bir seçenek olarak değerlendirilmektedir. Nitekim oral D3 vitamini desteğinin PLE şiddet skorunu %33,3 oranında azalttığı gösterilmiştir. Ayrıca, bir D vitamini analoğu olan topikal kalsipotriol kullanımının da proflaktik amaçla PLE lezyonlarının şiddetini %32 oranında azalttığı bildirilmiştir. Sonuç olarak, hem oral D vitamini takviyesi hem de topikal analoglar fotodermatoz tedavisinde güçlü alternatiflerdir.
Photodermatoses are skin disorders characterized by abnormal cutaneous reactions to ultraviolet radiation or visible light, with idiopathic photodermatoses (such as PLE and actinic prurigo) developing through immunologic mechanisms. In the pathogenesis of polymorphic light eruption (PLE), the most common type, an impaired immune response and T-cell activation against UV-induced neoantigens play a central role. Recent studies highlight the critical role of vitamin D in immunomodulation and immunosuppression; specifically, 1,25-(OH)2 D3 suppresses proinflammatory cytokines while stimulating Treg cells and anti-inflammatory cytokine production. Due to sun avoidance behaviors, protective clothing, and sunscreen application, cutaneous synthesis is obstructed in photodermatosis patients, leading to a high risk of vitamin D deficiency. Research demonstrates that serum vitamin D levels in PLE patients are significantly lower than those in healthy controls. Although phototherapy courses successfully boost cutaneous vitamin D production and alleviate symptoms, they concurrently induce DNA damage, making oral supplementation a preferred alternative. Clinical trials show that oral vitamin D3 supplementation reduces PLE severity scores by 33.3%. Furthermore, the prophylactic application of topical calcipotriol, a vitamin D analogue, has been reported to decrease PLE severity scores by 32%. Consequently, both oral vitamin D supplementation and topical analogues present effective alternative options in the management of photodermatoses.
Referanslar
Hawk J. Abnormal responses to ultraviolet radiation. Dermatology in General Medicine. 1993. https://ci.nii.ac.jp/naid/10016074124/
Pao C, Norris P, Corbett M, Hawk J. Polymorphic light eruption: prevalence in Australia and England. Br J Dermatol. 1994;130(1):62-4.
Wolf P, Gruber-Wackernagel A, Rinner B, et al. Phototherapeutic hardening modulates systemic cytokine levels in patients with polymorphic light eruption. Photochem Photobiol Sci. 2013;12(1):166-73.
Koulu LM, Laihia JK, Peltoniemi H-H, Jansén CT. UV-induced tolerance to a contact allergen is impaired in polymorphic light eruption. Journal of investigative dermatology. 2010;130(11):2578-82.
Segaert S, Bouillon R. Epidermal keratinocytes as source and target cells for vitamin D. İçinde 2000. s. 211.
Correale J, Ysrraelit MC, Gaitán MI. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain. 2009;132(5):1146-60.
May E, Asadullah K, Zugel U. Immunoregulation through 1, 25-dihydroxyvitamin D 3 and its analogs. Current Drug Targets-Inflammation & Allergy. 2004;3(4):377-93.
Calton E, Keane K, Newsholme P, Soares M. The Impact of Vitamin D Levels on Inflammatory Status: A Systematic Review of Immune Cell Studies. PloS one. 2015;10:e0141770.
Watkins RR, Lemonovich TL, Salata RA. An update on the association of vitamin D deficiency with common infectious diseases. Can J Physiol Pharmacol. 2015;93(5):363-8.
Kölgen W, van Meurs M, Jongsma M, et al. Differential expression of cytokines in UV-B–exposed skin of patients with polymorphous light eruption: correlation with Langerhans cell migration and immunosuppression. Arch Dermatol. 2004;140(3):295-302.
Fehérvari Z, Sakaguchi S. CD4+ Tregs and immune control. The Journal of clinical investigation. 2004;114(9):1209-17.
Gambichler T, Terras S, Kampilafkos P,et al. T regulatory cells and related immunoregulatory factors in polymorphic light eruption following ultraviolet A1 challenge. Br J Dermatol. 2013;169(6):1288-94.
Schwarz T. 25 years of UV‐induced immunosuppression mediated by T cells—from disregarded T suppressor cells to highly respected regulatory T cells. Photochem Photobiology. 2008;84(1):10-8.
Schweintzger N, Gruber‐Wackernagel A, Reginato E, et al. Levels and function of regulatory T cells in patients with polymorphic light eruption: relation to photohardening. Br J Dermatol. 2015;173(2):519-26.
Hawk J, Magnus I. Chronic actinic dermatitis-an idiopathic photosensitivity syndrome including actinic reticuloid and photosensitive eczema. Br J Dermatol. 1979;101:24.
Botto NC, Warshaw EM. Solar urticaria. Journal of the Amer Acad Dermatol. 2008;59(6):909-20.
Beattie PE, Dawe RS, Ibbotson SH, Ferguson J. Characteristics and prognosis of idiopathic solar urticaria: a cohort of 87 cases. Arch Dermatol. 2003;139(9):1149-54.
Gambichler T, Al-Muhammadi R, Boms S. Immunologically Mediated Photodermatoses: Diagnosis and Treatment. Amer J Clin Dermatol. 2009;10(3):169-80.
Hojyo-Tomoka T, Granados J, Vargas-Alarcón G, et al. Further evidence of the role of HLA-DR4 in the genetic susceptibility to actinic prurigo. J Am Acad Dermatol. 1997;36(6 Pt 1):935-7.
Preece M, Tomlinson S, Ribot C, et al. Studies of vitamin D deficiency in man. QJM: An International Journal of Medicine. 1975;44(4):575-89.
Holme SA, Anstey AV, Badminton MN, Elder GH. Serum 25-hydroxyvitamin D in erythropoietic protoporphyria. Br J Dermatol. 2008;159(1):211-3.
Cusack C, Danby C, Fallon JC, et al. Photoprotective behaviour and sunscreen use: impact on vitamin D levels in cutaneous lupus erythematosus. Photodermatol Photoimmunol Photomed. 2008;24(5):260-7.
Ruiz-Irastorza G, Egurbide MV, Olivares N, et al. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford). 2008;47(6):920-3.
Reid SM, Robinson M, Kerr AC, Ibbotson SH. Prevalence and predictors of low vitamin D status in patients referred to a tertiary photodiagnostic service: a retrospective study: Vitamin D status in patients with photosensitivity. Photodermatol Photoimmunol Photomed. 2012;28(2):91-6.
Gruber-Wackernagel A, Obermayer-Pietsch B, Byrne SN, Wolf P. Patients with polymorphic light eruption have decreased serum levels of 25-hydroxyvitamin-D3 that increase upon 311 nm UVB photohardening. Photochemical & Photobiological Sciences. 2012;11(12):1831-6.
Rhodes LE, Webb AR, Berry JL, et al. Sunlight exposure behaviour and vitamin D status in photosensitive patients: longitudinal comparative study with healthy individuals at U.K. latitude. Br J Dermatol. 2014;171(6):1478-86.
Garg N, Chandra A, Srivastava M, Dhillon K. Correlation between Serum Vit D3 Levels and Clinicoepidemiological Profile of Polymorphic Light Eruption Patients: An Interventional Study. 2020. https://www.researchgate.net/publication/350529919_Correlation_between_Serum_Vit_D3_Levels_and_Clinicoepidemiological_Profile_of_Polymorphic_Light_Eruption_Patients_An_Interventional_Study
Vähävihu K, Ylianttila L, Kautiainen H, et al. Narrowband ultraviolet B course improves vitamin D balance in women in winter. British Journal of Dermatology. 2010;162(4):848-53.
Petersen B, Wulf HC, Triguero-Mas M, et al. Sun and ski holidays improve vitamin D status, but are associated with high levels of DNA damage. J Invest Dermatol. Kasım 2014;134(11):2806-13.
Orekoya O, Rhodes LE, Osman JE, et al. A qualitative study of knowledge, behaviour and attitudes regarding vitamin D acquisition among patients with photosensitivity disorders. Photodermatol Photoimmunol Photomed. Eylül 2020;36(5):378-83.
Stafford R, Farrar MD, Kift R, et al. The impact of photosensitivity disorders on aspects of lifestyle. Br J Dermatol. 2010;163(4):817-22.
Bagot M, Charue D, Lescs MC, et al. Immunosuppressive effects of 1,25-dihydroxyvitamin D3 and its analogue calcipotriol on epidermal cells. Br J Dermatol. Nisan 1994;130(4):424-31.
Dam TN, Møller B, Hindkjaer J, Kragballe K. The vitamin D3 analog calcipotriol suppresses the number and antigen-presenting function of Langerhans cells in normal human skin. J Investig Dermatol Symp Proc. Nisan 1996;1(1):72-7.
Brown AJ. Therapeutic uses of vitamin D analogues. American journal of kidney diseases. 2001;38(5):S3-19.
Hanneman KK, Scull HM, Cooper KD, Baron ED. Effect of topical vitamin D analogue on in vivo contact sensitization. Archives of dermatology. 2006;142(10):1332-4.
Gruber-Wackernagel A, Bambach I, Legat FJ, et al. Randomized double-blinded placebo-controlled intra-individual trial on topical treatment with a 1,25-dihydroxyvitamin D3 analogue in polymorphic light eruption: Vitamin D3 analogue in PLE. British Journal of Dermatology. Temmuz 2011;165(1):152-63.
